Compare Cassava Sciences Inc (FLNA) vs Modine Manufacturing Company (MOD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cassava Sciences Inc vs Modine Manufacturing Company — how do they compare? Cassava Sciences Inc trades at $1.06 (market cap $53.14M), while Modine Manufacturing Company trades at $224.68 (market cap $12.32B). The key difference: Modine Manufacturing Company is far larger — about 231.8× Cassava Sciences Inc's market cap, and Modine Manufacturing Company is trading nearer its 52-week high, Cassava Sciences Inc nearer its low. Which is the better fit depends on your goals.
| FLNA | MOD | |
|---|---|---|
Market Cap | $53.14M | $12.32B |
Sector | Health | Technology |
52-Week High | $4.64 | $306.89 |
52-Week Low | $1.09 | $91.30 |
Enterprise Value | -$33.43M | $12.68B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FLNA trades at $1.06, down 2.75% today, with a bearish technical signal from moving averages but neutral oscillators. The stock shows a low P/B of 0.78, yet profitability metrics are negative, including a -79.59% ROE and -$90.97M net income for 2025. Recent Q1 2026 earnings beat expectations, and analyst consensus is 66.7% buy. News highlights Q1 financial results and a scientific presentation on TSC-related epilepsy therapies.
Outlook remains speculative due to persistent losses and negative cash flows, offset by strong analyst support and recent earnings beats. Key risks include funding needs for drug development and competitive pressures, while potential upside hinges on clinical progress in TSC-related epilepsy treatments.
Modine (MOD) trades at $222.31, down 3.16% with bearish technical signals, though it has beaten earnings estimates for three consecutive quarters. The company reported 2025 revenue of $2.58B with a net income margin of 3.82%, but faces a high P/E ratio of 102.64. Recent news includes the appointment of a new Commercial HVAC president and an upcoming Q1 2027 earnings call on July 30, 2026.
Analyst consensus is strongly bullish with a $328.80 price target, but high valuation and projected margin compression in 2026 present risks. The stock's near-term direction may hinge on Q2 2026 earnings versus the $1.38 estimate and execution in the data center and HVAC segments amid supply chain challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →About Modine Manufacturing Company
Modine Manufacturing Company is a global leader in thermal management technology and solutions. The company engineers, manufactures, and markets heat transfer products for a wide range of applications across the automotive, commercial, industrial, and HVAC (heating, ventilation, and air conditioning) markets. Modine's products include engine cooling systems, heat exchangers, and ventilation systems, providing critical thermal solutions for vehicles, data centers, and various equipment worldwide.
Read more on MOD →
